Life Without Glutamate

HALF FULL, HALF EMPTY, OR ...© 2004 AAASAfter each neurotransmitter release, MK801, an open-channel blocker that can only block a channel that has been activated, decreases initial current (which has been normalized for wild type and mutant cells). In the colocalization model, VGLUT1 and VGLUT2 occupy the same vesicles filling them partially. The commingling model proposes that transporters occupy distinct vesicles in the same synapse. The segregation model proposes that the transporters ar

Written byDavid Secko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© 2004 AAAS

After each neurotransmitter release, MK801, an open-channel blocker that can only block a channel that has been activated, decreases initial current (which has been normalized for wild type and mutant cells). In the colocalization model, VGLUT1 and VGLUT2 occupy the same vesicles filling them partially. The commingling model proposes that transporters occupy distinct vesicles in the same synapse. The segregation model proposes that the transporters are found in different synapses.

A brain without glutamate, the major excitatory neurotransmitter in mammals, is quite literally unthinkable. Yet, knockout mice lacking the crucial vesicular glutamate transporter, VGLUT1, can live for up to a few months. This unexpected finding has enabled two research groups to investigate the function of VGLUT1.

With potential links to learning and memory, as well as neurological diseases such as epilepsy, approaching glutamate transmission through the protein believed to load it into vesicles provides a useful starting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies